77 results
8-K
RYTM
Rhythm Pharmaceuticals Inc.
9 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
4:14pm
, and all other information in the Form 10-K remains unchanged. In order to preserve the nature and character of the disclosures set forth in the Form 10
8-K
RYTM
Rhythm Pharmaceuticals Inc.
16 Jun 22
Entry into a Material Definitive Agreement
5:11pm
for a transaction of this nature. Upon the occurrence of an event of default, the Investors may accelerate payments due under the Agreement up to the Hard Cap plus
8-K
EX-99.1
o036g4oa1szro8upa
14 May 18
Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results
4:01pm
8-K
EX-10.1
lkkmqbchw9bfnk
8 Jan 20
Rhythm Pharmaceuticals Announces Leadership Transition
4:00pm
8-K
EX-10.1
yqf9yf0gjknka0 anui8
3 Aug 23
Departure of Directors or Certain Officers
5:22pm